HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A 1:2 matched case-control study on the interaction of HPV16E6 and HLA-DR9 allele to esophageal cancer in Kazakh ethnicity, Xinjiang].

AbstractOBJECTIVE:
To evaluate the role and the association between HPV16E6 infection and HLA-DR9 immune-associated gene to esophageal cancer (EC) in Kazakh of Xinjiang, China.
METHODS:
A 1:2 matched case-control study was conducted with 63 cases of EC and 126 controls involved. The controls were matched by sex, nationality, area of residence and age within 5-year difference. HPV16E6 and HLA-DR9 allele were identified by PCR-SSP. Interaction was performed to identify risk factors.
RESULTS:
HPV16E6 infection and HLA-DR9 allele positive status were the risk factors for EC, with OR values as 2.67 (95%CI: 1.38 - 5.17) and 3.83 (95%CI: 1.48 - 9.96) respectively. The rate of HPV16E6 infection in individuals with HLA-DR9 allele was different from the ones who were HLA-DR9 allele free (chi(2) = 7.57, P = 0.006), with OR value as 5.79 (95%CI: 1.53 - 21.87). In the controls, the rates of HPV16E6 infection were 22.2% and 16.2% among individuals with HLA-DR9 allele atatus as positive or negative, and without statistically significant difference. Interaction analysis showed there was an interaction of HPV16E6 with HLA-DR9 and were higher than the sum of the two factors presented individually.
CONCLUSION:
In our study, we found that the HLA-DR9 allele and HPV16E6 infection had a function of synergy in the process of malignant transformation of esophageal epithelial cells, and jointly promoting the occurrence and development of EC.
AuthorsPei-hua Liao, Jiang-mei Qin, Tong-xia Zeng, Feng Li, Jin-feng Cai, Ling He
JournalZhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi (Zhonghua Liu Xing Bing Xue Za Zhi) Vol. 30 Issue 9 Pg. 951-4 (Sep 2009) ISSN: 0254-6450 [Print] China
PMID20193235 (Publication Type: English Abstract, Journal Article)
Chemical References
  • E6 protein, Human papillomavirus type 16
  • HLA-DR Antigens
  • HLA-DR Serological Subtypes
  • HLA-DR9 antigen
  • Oncogene Proteins, Viral
  • Repressor Proteins
Topics
  • Alleles
  • Case-Control Studies
  • Cell Transformation, Neoplastic (genetics)
  • China (epidemiology)
  • Epithelial Cells (pathology)
  • Esophageal Neoplasms (ethnology, etiology, genetics)
  • Esophagus (pathology)
  • HLA-DR Antigens (genetics)
  • HLA-DR Serological Subtypes
  • Humans
  • Oncogene Proteins, Viral
  • Papillomavirus Infections (complications)
  • Polymerase Chain Reaction
  • Repressor Proteins
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: